ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,263,070 | -18.7% | 16,810 | -17.3% | 0.02% | -17.2% |
| Q4 2022 | $7,703,508 | -40.0% | 20,335 | -44.1% | 0.03% | -38.3% |
| Q3 2022 | $12,833,000 | +31.8% | 36,350 | +41.4% | 0.05% | +14.6% |
| Q2 2022 | $9,739,000 | +1319.7% | 25,704 | +1081.2% | 0.04% | +1266.7% |
| Q1 2022 | $686,000 | -70.9% | 2,176 | -67.7% | 0.00% | -66.7% |
| Q4 2021 | $2,360,000 | +76.4% | 6,739 | +52.1% | 0.01% | +80.0% |
| Q3 2021 | $1,338,000 | +199.3% | 4,430 | +198.1% | 0.01% | +150.0% |
| Q2 2021 | $447,000 | – | 1,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 39,370 | $14,917,000 | 13.60% |
| Tri Locum Partners LP | 82,735 | $31,347,000 | 12.84% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,493,000 | 9.48% |
| Artal Group S.A. | 400,000 | $151,552,000 | 8.10% |
| Finepoint Capital LP | 52,800 | $20,005,000 | 6.92% |
| Paradigm Biocapital Advisors LP | 88,816 | $33,651,000 | 6.71% |
| Fairmount Funds Management LLC | 73,526 | $27,858,000 | 6.38% |
| DCF Advisers, LLC | 25,000 | $9,472,000 | 5.64% |
| Redmile Group, LLC | 385,818 | $146,179,000 | 5.58% |
| Eagle Health Investments LP | 60,300 | $22,846,000 | 5.33% |